Women May Be Able To 'Take Break' From Osteoporosis Drug Without Losing Benefit
Sun, 31 Dec 2006 08:00 AM EST
... Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect, according to a study in the December 27 issue of JAMA.Osteoporosis is common among postmenopausal women. [click link for full article] ...
Related Topics
- Osteoporosis
- Drug Safety
- Prescription Drugs
- Women's Health
- Drug Side Effects
- Protein-losing enteropathy
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Raloxifene
- Pamidronate Injection
- Stroke, if clots break off and travel to the brain (drugs that thin the blood such as heparin and warfarin can reduce the risk)
- Vitamin D
- Goldenseal
- Niacin
- Hyperthyroidism
- Teriparatide Injection
- Botulism Immune Globulin
- Pension

Not Signed In -

